NCT02672228 Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense) Status COMPLETED Phase NA
NCT02661373 First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor Status COMPLETED Phase PHASE1
NCT02659566 Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, Mali Status COMPLETED Phase N/A
NCT02658253 Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults Status COMPLETED Phase PHASE1
NCT02654912 Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration Status COMPLETED Phase PHASE4
NCT02654730 Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia Status TERMINATED Phase PHASE2/PHASE3
NCT02653898 Malaria Elimination Pilot Study in Military Forces in Cambodia Status UNKNOWN Phase PHASE4
NCT02645513 Text Message Reminders to Health Workers on Malaria, Pneumonia, and Diarrhea Case Management in Malawi Status COMPLETED Phase NA
NCT02639299 Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge Status RECRUITING Phase N/A
NCT02627456 Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali Status COMPLETED Phase PHASE1
NCT02613520 Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants Status COMPLETED Phase PHASE1
NCT02610400 Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia Status COMPLETED Phase PHASE3
NCT02605720 Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns Status COMPLETED Phase PHASE3
NCT02601716 PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults Status COMPLETED Phase PHASE2
NCT02600975 A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B Status COMPLETED Phase PHASE1
NCT02600767 Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil Status COMPLETED Phase NA
NCT02592408 A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan Status COMPLETED Phase PHASE4